BioCentury
ARTICLE | Company News

Avalon, Novartis drug discovery deal

September 14, 2005 12:30 AM UTC

Avalon (Germantown, Md.) and Novartis (NVS; SWX:NOVN) partnered to discover small molecule therapeutics targeted against an undisclosed pathway selected by NVS. Avalon will use its AvalonRx drug disco...